Latest Articles

Publication Date
All News Scientific
Proteomics International Secures Grant for Endometriosis Diagnostic Test - MSN

Proteomics International Secures Grant for Endometriosis Diagnostic Test MSN

Published: Nov. 25, 2025, 2:30 p.m.
Read Full Article
EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis - Markets Financial Content

EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis Markets Financial Content

Published: Nov. 25, 2025, 12:42 a.m.
Read Full Article
Acute Hemoperitoneum Secondary to Chronic Hematosalpinx: A Diagnostic Challenge in the Setting of a Negative Pregnancy Test - Cureus

Acute Hemoperitoneum Secondary to Chronic Hematosalpinx: A Diagnostic Challenge in the Setting of a Negative Pregnancy Test Cureus

Published: Nov. 20, 2025, 3:17 p.m.
Read Full Article
PIQ: Commercial ramp-up of four novel diagnostic tests targets major US and Australian markets - TradingView

PIQ: Commercial ramp-up of four novel diagnostic tests targets major US and Australian markets TradingView

Published: Nov. 20, 2025, 3:50 a.m.
Read Full Article
An assisted diagnostic and prognostic model for endometrial cancer using 36 serological markers and clinical variables from 562 patients - Nature

An assisted diagnostic and prognostic model for endometrial cancer using 36 serological markers and clinical variables from 562 patients Nature

Published: Nov. 18, 2025, 2:28 p.m.
Read Full Article
Promega wins FDA approval as companion diagnostic for Keytruda-Lenvima combo in uterine cancer - Fierce Biotech

Promega wins FDA approval as companion diagnostic for Keytruda-Lenvima combo in uterine cancer Fierce Biotech

Published: Nov. 13, 2025, 9 a.m.
Read Full Article
FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer - Voice Of HealthCare

FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer Voice Of HealthCare

Published: Nov. 13, 2025, 6:17 a.m.
Read Full Article
FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma - 뉴스와이어

FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma 뉴스와이어

Published: Nov. 13, 2025, 5:50 a.m.
Read Full Article
FDA Approves Diagnostic Tool for Pembrolizumab Combo in Endometrial Cancer - CancerNetwork

FDA Approves Diagnostic Tool for Pembrolizumab Combo in Endometrial Cancer CancerNetwork

Published: Nov. 12, 2025, 7:12 p.m.
Read Full Article
Gynaecological Devices Market Set to Reach USD 21.11 Billion By 2033, Due to Advances in Surgical and Diagnostic Technologies – SNS Insider - Business Upturn

Gynaecological Devices Market Set to Reach USD 21.11 Billion By 2033, Due to Advances in Surgical and Diagnostic Technologies – SNS Insider Business Upturn

Published: Nov. 12, 2025, 1 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!